BridGene Biosciences: Funding, Investors & Team (Oct 2026)
BridGene Biosciences is a biotechnology organization utilizing front line chemoproteomic innovation to find and foster little particles. It empowers covalent little particles to perform vast separating live cells, which brings about profoundly specific little atoms that drug customarily undruggable targets.
BridGene Biosciences has raised $66.5M across 2 funding rounds on record, the most recent a Series B of $28.0M announced in Oct 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BridGene Biosciences Company Profile and Key Stats
Latest funding round on record: Oct 2025.
BridGene Biosciences Funding Rounds
BridGene Biosciences raised $38.5M in a Series B announced in Jul 2022.
3.3 years later, a Series B of $28.0M was announced in Oct 2025.
BridGene Biosciences Founders and Leadership Team
Contact details for the BridGene Biosciences team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →BridGene Biosciences Funding Compared to Other Biotechnology Startups
BridGene Biosciences' latest round of $28.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BridGene Biosciences in Biotechnology and Sunnyvale
Companies Similar to BridGene Biosciences
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
BridGene Biosciences Funding FAQs
What does BridGene Biosciences do?
BridGene Biosciences is a biotechnology organization utilizing front line chemoproteomic innovation to find and foster little particles. It empowers covalent little particles to perform vast separating live cells, which brings about profoundly specific little atoms that drug customarily undruggable targets.
How much funding has BridGene Biosciences raised?
BridGene Biosciences has raised $66.5M across 2 rounds on record. The most recent is a Series B of $28.0M announced in Oct 2025.
When did BridGene Biosciences last raise funding?
BridGene Biosciences' most recent funding round on record is a Series B of $28.0M, announced in Oct 2025.
Who is the CEO of BridGene Biosciences?
Ping C. is listed as CEO at BridGene Biosciences.
Where is BridGene Biosciences headquartered?
BridGene Biosciences is based in Sunnyvale, California, United States.
How many employees does BridGene Biosciences have?
BridGene Biosciences is in the 1-10 employee band.
How does BridGene Biosciences' funding compare to other Biotechnology startups?
BridGene Biosciences' latest round of $28.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's BridGene Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BridGene Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.